Fig. 5.
Fig. 5. Effect of Ado receptor antagonists on fMLP-induced PLD activity. / 1-O-[3H]alkyl-2-lysophosphatidylcholine-labeled neutrophils were preincubated at 37°C for 5 minutes. The cell suspensions were then pretreated with 10 μmol/L CB and increasing concentrations of either CGS15943 (A) or CSC (B) and incubated in the presence or absence of 0.1 U/mL ADA for 5 minutes. Neutrophils were stimulated with 0.1 μmol/L fMLP in the presence of 1% ethanol for 10 minutes. The amount of radioactivity incorporated into [3H]PEt was assessed as described in “Materials and Methods” and is expressed as the percentage of the radioactivity in the total lipid extracts. The data are the means ± SEM of 3 separate experiments.

Effect of Ado receptor antagonists on fMLP-induced PLD activity.

1-O-[3H]alkyl-2-lysophosphatidylcholine-labeled neutrophils were preincubated at 37°C for 5 minutes. The cell suspensions were then pretreated with 10 μmol/L CB and increasing concentrations of either CGS15943 (A) or CSC (B) and incubated in the presence or absence of 0.1 U/mL ADA for 5 minutes. Neutrophils were stimulated with 0.1 μmol/L fMLP in the presence of 1% ethanol for 10 minutes. The amount of radioactivity incorporated into [3H]PEt was assessed as described in “Materials and Methods” and is expressed as the percentage of the radioactivity in the total lipid extracts. The data are the means ± SEM of 3 separate experiments.

Close Modal

or Create an Account

Close Modal
Close Modal